✦ LIBER ✦

nab-paclitaxel + gemcitabine promising for pancreatic cancer

Book ID: 120844596
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816360-00020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nab-paclitaxel shows promise in pancreat

Nab-paclitaxel shows promise in pancreatic cancer

✍ Baker, Holly 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 212 KB

Increased Survival in Pancreatic Cancer

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

✍ Von Hoff, Daniel D.; Ervin, Thomas; Arena, Francis P.; Chiorean, E. Gabriela; In 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 637 KB

A phase I trial of nab-paclitaxel, gemci

A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer

✍ Andrew H. Ko, Thach-Giao Truong, Emily Kantoff… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 219 KB

Bevacizumab + gemcitabine promising for

Bevacizumab + gemcitabine promising for pancreatic cancer

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Talabostat plus gemcitabine promising fo

Talabostat plus gemcitabine promising for metastatic pancreatic cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Quality-adjusted survival with combinati

Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis

✍ Reni, Michele; Wan, Yin; Solem, Caitlyn; Whiting, Scott; Ji, Xiang; Botteman, Ma 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 545 KB